Eye Health News and Research

Latest Eye Health News and Research

Nearly half of patients see improvement by switching to different lens/solution combination, says study

If your contact lenses are causing you discomfort, simply switching to a different type of contact lens or lens care product may bring improvement, reports a study, " Effect of Lens and Solution Choice on the Comfort of Contact Lens Wearers", appearing in the May issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

2 May 2013

Exposure to daylight helps protect children from myopia

Two new studies add to the growing evidence that spending time outdoors may help prevent or minimize nearsightedness in children. A study conducted in Taiwan, which is the first to use an educational policy as a public vision health intervention, finds that when children are required to spend recess time outdoors, their risk of nearsightedness is reduced.

2 May 2013

First Edition: April 30, 2013

Today's headlines include reports that the Obama administration has simplified the application for health insurance benefits under the health law.

30 Apr 2013

Viewpoints: Bowles, Simpson renew push for 'grand bargain;' The debate on FDA oversight of pharmacies; Kasich and feds work to find formula for Medicaid expansion

To be sure, some progress has been made the past two years. Policymakers have enacted about $2.7 trillion in deficit reduction, primarily through cuts in discretionary spending and higher taxes on wealthy individuals. Yet what we have achieved so far is insufficient.

30 Apr 2013

IL-1 antagonist relieves dry eyes

Clinical trial results point to a role for interleukin-1 targeted agents for the treatment of dry eye disease associated with meibomian gland dysfunction.

29 Apr 2013

Ocular tuberculosis presents a diagnostic challenge

Mycobacterial ocular inflammation typically arises without concomitant systemic or pulmonary disease and should be suspected in patients who do not respond to anti-inflammatory therapy.

29 Apr 2013

Alimera announces availability of ILUVIEN in U.K. for chronic DME treatment

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that ILUVIEN®, the first sustained release pharmaceutical product for the treatment of chronic diabetic macular edema, is now available in the United Kingdom.

29 Apr 2013

Md. insurer proposes 25% rate hike because of health reform

The state's largest insurer -- CareFirst BlueCross BlueShield -- wants to raise rates for individuals buying coverage on their own in order to offset the cost of the health law requiring that insurers accept patients with pre-existing conditions.

26 Apr 2013

High-energy proton beam therapy offers potential treatment option for eye cancer

Particle beams - from low energy beams with exotic ions through to extremely high energy light sources - are revolutionising the way we view the world and creating potential for new industries, but the instrumentation for controlling the beams is still in its infancy.

26 Apr 2013

Scientists develop new technique for imaging nanoparticle dynamics with atomic resolution

The macroscopic effects of certain nanoparticles on human health have long been clear to the naked eye. What scientists have lacked is the ability to see the detailed movements of individual particles that give rise to those effects.

26 Apr 2013

Fixed-dose combination of drugs effectively lowers IOP

A fixed-dose combination of brinzolamide and brimonidine is more effective than either drug given alone for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, results of a phase III trial indicate.

25 Apr 2013

Omeros presents clinical data of OMS302 on reducing pupil constriction during ILR at ASCRS meeting

Omeros Corporation today reported analyses of Phase 2 and Phase 3 clinical data showing the favorable impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement.

25 Apr 2013

Acucela begins phase 2b/3 clinical trial of emixustat hydrochloride to treat GA associated with dry AMD

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for sight threatening eye diseases, today announced that a phase 2b/3 clinical trial investigating emixustat hydrochloride in subjects with geographic atrophy associated with dry age-related macular degeneration has been initiated.

25 Apr 2013

Retinoblastoma more invasive at diagnosis in racial, ethnic minority children

When the eye cancer retinoblastoma is diagnosed in racial and ethnic minority children whose families don't have private health insurance, it often takes a more invasive, potentially life-threatening course than in other children, probably because of delays in diagnosis, Dana-Farber/Children's Hospital Cancer Center researchers will report at the 26th annual meeting of the American Society of Pediatric Hematology Oncology being held in Miami, April 24-27.

25 Apr 2013

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn’t. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

24 Apr 2013

Study reveals 3-D motion detection system could help prevent shoulder injuries in baseball pitchers

A new 3-D motion detection system could help identify baseball pitchers who are at risk for shoulder injuries, according to a new study.

24 Apr 2013

New visual search rehabilitation game for visually impaired children

Visually impaired children could benefit from a revolutionary new computer game being developed by a team of neuroscientists and game designers.

24 Apr 2013

BD receives FDA approval for second prefilled injectable drug

BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD, announced today that the U.S. Food and Drug Administration has approved the second drug to be offered in the recently launched BD Simplist line of ready-to-administer prefilled generic injectables.

From BD (Becton, Dickinson and Company) 24 Apr 2013

PPMI to launch additional study to evaluate multiple potential biomarkers for Parkinson's disease

The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.

24 Apr 2013

Home-based health education about diseases most effective, finds study

In the first study of its kind, lay health workers increased screening rates for hepatitis B virus (HBV) and knowledge about the disease among a group of Asian Americans, known as the Hmong, UC Davis researchers have found.

24 Apr 2013

Eye Health News and Research

Latest Eye Health News and Research

Nearly half of patients see improvement by switching to different lens/solution combination, says study

Exposure to daylight helps protect children from myopia

First Edition: April 30, 2013

Viewpoints: Bowles, Simpson renew push for 'grand bargain;' The debate on FDA oversight of pharmacies; Kasich and feds work to find formula for Medicaid expansion

IL-1 antagonist relieves dry eyes

Ocular tuberculosis presents a diagnostic challenge

Alimera announces availability of ILUVIEN in U.K. for chronic DME treatment

Md. insurer proposes 25% rate hike because of health reform

High-energy proton beam therapy offers potential treatment option for eye cancer

Scientists develop new technique for imaging nanoparticle dynamics with atomic resolution

Fixed-dose combination of drugs effectively lowers IOP

Omeros presents clinical data of OMS302 on reducing pupil constriction during ILR at ASCRS meeting

Acucela begins phase 2b/3 clinical trial of emixustat hydrochloride to treat GA associated with dry AMD

Retinoblastoma more invasive at diagnosis in racial, ethnic minority children

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Study reveals 3-D motion detection system could help prevent shoulder injuries in baseball pitchers

New visual search rehabilitation game for visually impaired children

BD receives FDA approval for second prefilled injectable drug

PPMI to launch additional study to evaluate multiple potential biomarkers for Parkinson's disease

Home-based health education about diseases most effective, finds study

Industry Focus eBook: Oncology eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Eye Health News and Research

Latest Eye Health News and Research

Industry Focus eBook: Oncology eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in